Viviane Abreu Pedreira de Oliveira , Marcela Próspero Rodrigues Pinto , Daniela Farias Larangeira , Laís Pereira Silva , Vitor de Moraes Pina de Carvalho , Gisele André Baptista Canuto , Hanna Carvalho de Sá , Gabriel Rodrigues Menezes , Karine Araújo Damasceno , Stella Maria Barrouin-Melo , Alessandra Estrela-Lima
{"title":"Oxidative analysis, clinical-laboratory parameters, and quality of life in treatment associated with ozone therapy in female dogs with mammary tumors","authors":"Viviane Abreu Pedreira de Oliveira , Marcela Próspero Rodrigues Pinto , Daniela Farias Larangeira , Laís Pereira Silva , Vitor de Moraes Pina de Carvalho , Gisele André Baptista Canuto , Hanna Carvalho de Sá , Gabriel Rodrigues Menezes , Karine Araújo Damasceno , Stella Maria Barrouin-Melo , Alessandra Estrela-Lima","doi":"10.1016/j.rvsc.2025.105839","DOIUrl":null,"url":null,"abstract":"<div><div>Canine mammary tumors (CMT) primarily affect female dogs. Their high prevalence, chronic nature, and potential aggressiveness often lead to metastasis, systemic disease, and death despite the use of conventional treatment based on surgery and chemotherapy. There is a need for complementary, accessible, and low-cost therapies to improve the perioperative care of these canine patients. In this context, this study aimed to evaluate the effectiveness of ozonated autohemotherapy as an integrative therapy by analyzing markers of oxidative balance, clinical-laboratory parameters, and quality of life of dogs with CMT. Forty-nine dogs were examined and allocated into study groups: dogs treated with only mastectomy (GM; <em>n</em> = 11), mastectomy with ozonated autohemotherapy (GM-AHmO<sub>3</sub>; <em>n</em> = 13), and mastectomy with non-ozonated autohemotherapy (GM-AHm; <em>n</em> = 12); a fourth group contained negative control healthy dogs (GH; n = 13). Assessment of clinical, hematological (erythrocytes, platelets, lymphocytes, urea, creatinine, ALT, ALP), oxidative markers (TAC and MDA), and quality-of-life was performed at five-day points, D0, D1, D2, D3, and D4. The GM-AHmO<sub>3</sub> showed progressive improvement in quality-of-life scores (from 26.4 to 32; <em>p</em> < 0.001), increased total antioxidant capacity (TAC: 13.1 to 16.1; <em>p</em> = 0.003), and decreased malondialdehyde levels (MDA: 438 to 150.5; <em>p</em> = 0.002) from D0 to D4. Significant reductions were observed in creatinine (<em>p</em> = 0.006), ALT (<em>p</em> = 0.001), and ALP (<em>p</em> = 0.043) in GM-AHmO<sub>3</sub>, indicating improvement in renal and hepatic profiles. Additionally, a significant decrease in creatinine levels was noted at D4 in GM-AHmO<sub>3</sub> (<em>p</em> = 0.017). Comparative data between groups and time points showed that ozonated autohemotherapy enhanced antioxidant responses, reduced oxidative stress, improved renal and hepatic functions, and, importantly, improved CMT patients' life quality. As a preliminary investigation, this study indicates that AHmO<sub>3</sub> is a beneficial approach as a complementary method to enhance the well-being of dogs with CMTs undergoing mastectomy.</div></div>","PeriodicalId":21083,"journal":{"name":"Research in veterinary science","volume":"195 ","pages":"Article 105839"},"PeriodicalIF":1.8000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in veterinary science","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0034528825003133","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Canine mammary tumors (CMT) primarily affect female dogs. Their high prevalence, chronic nature, and potential aggressiveness often lead to metastasis, systemic disease, and death despite the use of conventional treatment based on surgery and chemotherapy. There is a need for complementary, accessible, and low-cost therapies to improve the perioperative care of these canine patients. In this context, this study aimed to evaluate the effectiveness of ozonated autohemotherapy as an integrative therapy by analyzing markers of oxidative balance, clinical-laboratory parameters, and quality of life of dogs with CMT. Forty-nine dogs were examined and allocated into study groups: dogs treated with only mastectomy (GM; n = 11), mastectomy with ozonated autohemotherapy (GM-AHmO3; n = 13), and mastectomy with non-ozonated autohemotherapy (GM-AHm; n = 12); a fourth group contained negative control healthy dogs (GH; n = 13). Assessment of clinical, hematological (erythrocytes, platelets, lymphocytes, urea, creatinine, ALT, ALP), oxidative markers (TAC and MDA), and quality-of-life was performed at five-day points, D0, D1, D2, D3, and D4. The GM-AHmO3 showed progressive improvement in quality-of-life scores (from 26.4 to 32; p < 0.001), increased total antioxidant capacity (TAC: 13.1 to 16.1; p = 0.003), and decreased malondialdehyde levels (MDA: 438 to 150.5; p = 0.002) from D0 to D4. Significant reductions were observed in creatinine (p = 0.006), ALT (p = 0.001), and ALP (p = 0.043) in GM-AHmO3, indicating improvement in renal and hepatic profiles. Additionally, a significant decrease in creatinine levels was noted at D4 in GM-AHmO3 (p = 0.017). Comparative data between groups and time points showed that ozonated autohemotherapy enhanced antioxidant responses, reduced oxidative stress, improved renal and hepatic functions, and, importantly, improved CMT patients' life quality. As a preliminary investigation, this study indicates that AHmO3 is a beneficial approach as a complementary method to enhance the well-being of dogs with CMTs undergoing mastectomy.
期刊介绍:
Research in Veterinary Science is an International multi-disciplinary journal publishing original articles, reviews and short communications of a high scientific and ethical standard in all aspects of veterinary and biomedical research.
The primary aim of the journal is to inform veterinary and biomedical scientists of significant advances in veterinary and related research through prompt publication and dissemination. Secondly, the journal aims to provide a general multi-disciplinary forum for discussion and debate of news and issues concerning veterinary science. Thirdly, to promote the dissemination of knowledge to a broader range of professions, globally.
High quality papers on all species of animals are considered, particularly those considered to be of high scientific importance and originality, and with interdisciplinary interest. The journal encourages papers providing results that have clear implications for understanding disease pathogenesis and for the development of control measures or treatments, as well as those dealing with a comparative biomedical approach, which represents a substantial improvement to animal and human health.
Studies without a robust scientific hypothesis or that are preliminary, or of weak originality, as well as negative results, are not appropriate for the journal. Furthermore, observational approaches, case studies or field reports lacking an advancement in general knowledge do not fall within the scope of the journal.